How have GRI shares performed in 2024?

GRI Bio's stock was trading at 2.70 at the beginning of the year. Since then, GRI shares have decreased by 50.3% and is now trading at 1.34. View the best growth stocks for 2024 here .

When is GRI Bio's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, February 23rd 2024. View our GRI earnings forecast .

How were GRI Bio's earnings last quarter?

GRI Bio, Inc. (NASDAQ:GRI) posted its earnings results on Tuesday, November, 14th. The company reported ($3.64) earnings per share for the quarter.

When did GRI Bio's stock split?

Shares of GRI Bio reverse split on the morning of Tuesday, January 30th 2024. The 1-7 reverse split was announced on Tuesday, January 30th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, January 30th 2024. An investor that had 100 shares of stock prior to the reverse split would have 14 shares after the split.

How do I buy shares of GRI Bio?

Shares of GRI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:GRI

GRI Bio (GRI) Stock Price, News & Analysis

1.34

+0.09 (+7.20%)

(As of 02/9/2024 08:56 PM ET)

Compare

Today's Range: 1.24
▼
1.62
50-Day Range: 1.20
▼
5.16
52-Week Range: 1.08
▼
258.30

Volume: 969,800 shs
Average Volume: 1.08 million shs
Market Capitalization: $871,000.00

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Competitors Earnings Financials Headlines SEC Filings Short Interest Social Media

Get GRI Bio alerts:

About GRI Bio Stock (NASDAQ:GRI)

GRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on treating inflammatory, fibrotic, and autoimmune diseases in the United States. Its product pipeline comprises GRI-0621, which is in phase II clinical development for the treatment of idiopathic pulmonary fibrosis; GRI-0803 which is in phase I trial for the treatment of systematic lupus erythematosus; GRI-0124, which is in pre-clinical development for the treatment of primary sclerosing cholangitis; and GRI-0729 in pre-clinical development. The company also develops ADAIR and ADMIR for treatment of attention -deficit/hyperactivity disorder. GRI Bio, Inc. was formerly known as Glycoregimmune, Inc. GRI Bio, Inc. was founded in 2009 and is based in LA Jolla, California.

GRI Stock Price History

30 days | 90 days | 365 days | Advanced Chart

GRI Stock News Headlines

February 5, 2024 | americanbankingnews.com

GRI Bio (NASDAQ:GRI) & BioMarin Pharmaceutical (NASDAQ:BMRN) Critical Contrast

February 3, 2024 | msn.com

GRI Bio Launches Major Securities Public Offering

February 12, 2024 | Edge On The Street (Ad)

An Unusual Way to Invest in Gold

Most financial experts recommend including gold in your investment mix to protect against rising prices and keep wealth secure. Investors are discovering a little-known way to benefit from gold, which offers the chance to gain from higher gold prices and mining successes while avoiding the costs of operating mines.

February 2, 2024 | msn.com

GRI Bio prices 5M shares at $1.10 in public offering

February 2, 2024 | marketwatch.com

GRI Bio Shares Drop After Stock Offering Prices Below Thursday's Close

February 2, 2024 | markets.businessinsider.com

GRI Bio Announces Pricing Of $5.5 Mln Public Offering, Stock Down

February 2, 2024 | investorplace.com

Why Is GRI Bio (GRI) Stock Down 21% Today?

January 26, 2024 | finanznachrichten.de

GRI Bio, Inc.: GRI Bio Announces Reverse Stock Split

February 12, 2024 | Edge On The Street (Ad)

An Unusual Way to Invest in Gold

January 26, 2024 | msn.com

GRI Bio's board OKs 1-for-7 reverse stock split

January 26, 2024 | finance.yahoo.com

GRI Bio Announces Reverse Stock Split

January 9, 2024 | finance.yahoo.com

GRI Bio, Inc. (GRI) Stock Historical Prices & Data - Yahoo Finance

January 3, 2024 | chicago.suntimes.com

Weed dispensary plan scrapped at old Rainforest Cafe in River North

December 21, 2023 | msn.com

GRI Bio files to sell common stock, warrants

November 27, 2023 | markets.businessinsider.com

GRI Bio Says FDA Clears IND For GRI-0621 For Treatment Of IPF; Stock Up 19%

November 27, 2023 | msn.com

GRI Bio stock slides 9% amid FDA clearance for testing of IPF drug

November 24, 2023 | morningstar.com

GRI Bio Inc GRI

November 15, 2023 | finanznachrichten.de

GRI Bio, Inc.: GRI Bio (NASDAQ: GRI) Reports Third Quarter 2023 Financial Results and Provides Corporate Update

November 15, 2023 | msn.com

GRI Bio reports Q3 results

November 6, 2023 | msn.com

Lawsuit alleges plan to open a marijuana store in former Rainforest Cafe is illegal

October 31, 2023 | chicago.suntimes.com

Pot shop company files suit to blunt planned dispensary at former Rainforest Cafe, limit proximity of minority-owned stores

October 17, 2023 | markets.businessinsider.com

GRI Bio Partners With NIHR Respiratory TRC To Advance NKT Regulation Technology - Quick Facts

October 11, 2023 | finance.yahoo.com

GRI Bio (NASDAQ: GRI) to Participate in the Virtual Investor Ask the CEO Conference

September 29, 2023 | finanznachrichten.de

GRI Bio, Inc.: September Is Pulmonary Fibrosis Awareness Month: Here's What One Company Is Doing To Develop A Treatment For This Deadly Disease

September 18, 2023 | benzinga.com

Thinking about buying stock in SeqLL, GRI Bio, Earlyworks Co, TradeUP Acquisition, or Safety Shot?

September 15, 2023 | benzinga.com

Disease With Market Estimated At $3.9 Billion Lacks Cure – Will This Company Be The First To Find One?

September 8, 2023 | msn.com

Elon Musk blocked Ukrainian attack on Russia's Black Sea fleet, says new biography

See More Headlines

Receive GRI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GRI Bio and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/14/2023
Today: 2/11/2024
Next Earnings (Estimated): 2/23/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Current Symbol: NASDAQ:GRI
CUSIP: N/A
CIK: 1824293
Web: www.vallon-pharma.com
Phone: 267-607-8255
Fax: N/A
Employees: 1
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): -81.48
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-7,020,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -595.60%
Return on Assets: -315.73%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 2.01
Quick Ratio: 2.01

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: 38.62 per share
Price / Book: 0.03

Miscellaneous

Outstanding Shares: 650,000
Free Float: 537,000
Market Cap: $871,000.00
Optionable: Not Optionable
Beta: -1.64

10 Best Cheap Stocks to Buy Now

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

Dr. W. Marc Hertz Ph.D. (Age 54)
Co-Founder, CEO, President & Director
Dr. Vipin Kumar Chaturvedi Ph.D. (Age 65)
Co-Founder & Chief Scientific Officer
Ms. Leanne M. Kelly (Age 47)
CFO & Corporate Secretary
Dr. Albert Agro Ph.d. (Age 59)
Chief Medical Officer

Key Competitors

View All Competitors

GRI Stock Analysis - Frequently Asked Questions

How have GRI shares performed in 2024?: GRI Bio's stock was trading at 2.70 at the beginning of the year. Since then, GRI shares have decreased by 50.3% and is now trading at 1.34.
View the best growth stocks for 2024 here.
When is GRI Bio's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Friday, February 23rd 2024.
View our GRI earnings forecast.
How were GRI Bio's earnings last quarter?: GRI Bio, Inc. (NASDAQ:GRI) posted its earnings results on Tuesday, November, 14th. The company reported ($3.64) earnings per share for the quarter.

When did GRI Bio's stock split?: Shares of GRI Bio reverse split on the morning of Tuesday, January 30th 2024. The 1-7 reverse split was announced on Tuesday, January 30th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, January 30th 2024. An investor that had 100 shares of stock prior to the reverse split would have 14 shares after the split.
How do I buy shares of GRI Bio?: Shares of GRI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:GRI) was last updated on 2/12/2024 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial